Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Free Radic Biol Med. 2013 Sep 16;65:10.1016/j.freeradbiomed.2013.09.004. doi: 10.1016/j.freeradbiomed.2013.09.004

Table 1.

Effect of α-TTP KO on body weight and bone mass and architecture in the femur and lumbar vertebra of 22- to 24-month-old male and female mice.

Males
Females
Endpoint WT (n=10) KO (n=6) T-Test
(P=)
WT (n=3) KO (n=10) T-Test
(P=)
   Body weight (g) 33.3 ± 0.7 30.8 ± 1.6 0.13 27.8 ± 0.8 23.7 ± 1.2 0.18
Dual Energy X-ray Absorptiometry (DXA)
Femur
   Bone area (cm2) 0.509 ± 0.009 0.483 ± 0.010 0.11 0.447 ± 0.011 0.461 ± 0.012 0.54
   BMC (mg) 0.025 ± 0.001 0.022 ± 0.001 0.05 0.019 ± 0.002 0.020 ± 0.001 0.66
   BMD (mg/cm2) 0.048 ± 0.001 0.045 ± 0.001 0.07 0.041 ± 0.003 0.042 ± 0.001 0.72
Micro-computed Tomography (μCT)
Femur
   Bone volume (mm3) 20.3 ± 0.8 18.5 ± 0.6 0.10 16.5 ± 1.4 16.7 ± 0.8 0.89
Femur Diaphysis (cortical bone)
   Cross-sectional volume (mm3) 0.58 ± 0.01 0.54 ± 0.01 0.01 0.46 ± 0.01 0.46 ± 0.02 0.97
   Cortical volume (mm3) 0.23 ± 0.01 0.20 ± 0.01 0.01 0.16 ± 0.01 0.17 ± 0.01 0.83
   Marrow volume (mm3) 0.35 ± 0.01 0.34 ± 0.01 0.60 0.30 ± 0.00 0.30 ± 0.02 0.89
   Cortical thickness (μm) 199 ± 7 178 ± 6 0.04 161 ± 11 166 ± 5 0.65
   Ipolar (mm) 0.73 ± 0.03 0.59 ± 0.02 0.01 0.40 ± 0.03 0.42 ± 0.04 0.87
Femur Metaphysis (cancellous bone)
   Bone volume/tissue volume (%) 4.4 ± 0.8 4.4 ± 0.8 0.99 0.5 ± 0.3 0.5 ± 0.1 0.94
   Trabecular number (1/mm) 3.2 ± 0.1 3.2 ± 0.1 0.92 2.7 ± 0.1 2.8 ± 0.2 0.85
   Trabecular thickness (μm) 45 ± 2 40 ± 1 0.10 31 ± 10 37 ± 2 0.37
   Trabecular spacing (μm) 342 ± 9 319 ± 9 0.13 373 ± 16 380 ± 21 0.86
Lumbar Vertebra (cancellous)
   Bone volume/tissue volume (%) 14.9 ± 1.3 16.3 ± 1.5 0.51 10.7 ± 2.1 12.1 ± 1.4 0.61
   Trabecular number (1/mm) 4.1 ± 0.2 4.1 ± 0.3 0.93 2.6 ± 0.2 2.6 ± 0.1 0.82
   Trabecular thickness (μm) 41 ± 1 43 ± 1 0.41 40 ± 2 45 ± 1 0.14
   Trabecular spacing (μm) 248 ± 15 242 ± 20 0.81 407 ± 32 398 ± 20 0.83

Data are mean ± SE

HHS Vulnerability Disclosure